Similar articles

• [A particular risk of prolonged immunosuppressive treatment: a case of acute myelomonocytic leukemia after chlorambucil treatment of severe rheumatoid arhtritis].

  Cazalis P, Caroit M, Zittoun R, Kahn MF, Sèze S. Cazalis P, et al. Rev Rhum Mal Osteoartic. 1976 Jun;43(6):431-5. Rev Rhum Mal Osteoartic. 1976. PMID: 781790 French. No abstract available.
• The action of antitumor agents: a double-edged sword?

  Sieber SM. Sieber SM. Med Pediatr Oncol. 1977;3(2):123-31. doi: 10.1002/mpo.2950030203. Med Pediatr Oncol. 1977. PMID: 327250 Review.
• Cancer and secondary leukemia.

  Rosner F. Rosner F. Bull Cancer. 1983;70(1):55-60. Bull Cancer. 1983. PMID: 6573207
• Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.

  Glicksman AS, Pajak TF, Gottlieb A, Nissen N, Stutzman L, Cooper MR. Glicksman AS, et al. Cancer Treat Rep. 1982 Apr;66(4):1035-44. Cancer Treat Rep. 1982. PMID: 6951632 No abstract available.
• Leukaemia and cancer in relation to immunosuppressive therapy.

  Videbaek A. Videbaek A. Scand J Haematol. 1973;10(4):241-3. doi: 10.1111/j.1600-0609.1973.tb00067.x. Scand J Haematol. 1973. PMID: 4587559 Review. No abstract available.